Education

Education

Patient-focused resources, tips from experts, and challenging clinical questions from ASH Clinical News

Instruction Without Lecture: Losing the Crutch

Despite being an inefficient way to educate people, the lecture has remained the most commonly employed method for delivering course material in medical schools....

Understanding Non-Hodgkin Lymphoma

There are two major types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). NHL is the sixth most common cancer in men and the...
You Make the Call

Is it reasonable to use rivaroxaban as an antithrombotic drug in obese patients?

This month, Kenneth A. Bauer, MD, advises on the use of target-specific oral anticoagulants in obese patients.Is it reasonable to use rivaroxaban as an antithrombotic...

Understanding MDS

Myelodysplastic syndromes (MDS) are a group of diseases of the bone marrow and blood that affect approximately 19,000 people in the United States. For...

From the Hudson River to the Hematology Wards: Why Simulation of Intrathecal Chemotherapy Can...

Let’s start with two case examples: “Mr. M” is a 36-year-old male with newly diagnosed B-cell acute lymphocytic leukemia (ALL) who presents with diplopia,...

Ten Things Doctors and Patients Should Question: An Update from the Choosing Wisely Task...

Choosing Wisely®, an initiative of the American Board of Internal Medicine (ABIM) Foundation, is a campaign that encourages clinicians and patients to engage in...
You Make the Call

Is pegfilgrastim with ABVD in Hodgkin lymphoma necessary?

This month, Sonali M. Smith, MD, advises on the use of pegfilgrastim with ABVD for treating Hodgkin lymphoma. What is your opinion on the use...
You Make the Call

From ASH Meeting on Hematologic Malignancies: How would you treat a patient with nodular...

During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the...

Clinical Trials 101

A clinical trial is a research study involving human volunteers to evaluate new ways to prevent, diagnose, or treat diseases. Clinical trials help determine...

The “KIST” Principle of Teaching

I have been practicing hematology for a long time. I have attended many ASH meetings, including innumerable education, scientific, and poster sessions. After every...
Advertisement

Current Issue

May 2021 Volume 7 Issue 6

This issue provides an update on gene therapies in hematology, demystifies RNA sequencing, and more.

Block title